Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Walter J. Curran
ResearcherPublications, citations & collaboration network
Walter J. Curran is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 1,135 works, 59,127 citations, an h-index of 109 and an i10-index of 491.
1,135
Works
59,127
Citations
109
h-index
491
i10-index
How has Walter J. Curran's publication output changed over time?
ScholarIQpublication output · 2000–2019
Output grew100% over the shown period — from 1 works in 2000 to 2 in 2019.
1
1
1
1
1
1
1
1
2
2
2000200420072010201120132014201520162019
What are the most-cited papers on Walter J. Curran?
ScholarIQmost cited works
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch, Giorgio V. Scagliotti, James L. Mulshine, Regina Kwon, Walter J. Curran, Yi‐Long Wu, Luis Paz‐Ares
The Lancet. 20163,375 CitationsOPEN ACCESS
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert, James J. Dignam, Terri S. Armstrong, Jeffrey S. Wefel, Deborah T. Blumenthal, Michael A. Vogelbaum, Howard Colman, Arnab Chakravarti, Stephanie L. Pugh, Minhee Won, Robert Jeraj, Paul D. Brown, Kurt A. Jaeckle, David Schiff, Volker W. Stieber, David Brachman, Maria Werner‐Wasik, Ivo W. Tremont‐Lukats, Erik P. Sulman, Kenneth Aldape, Walter J. Curran, Minesh P. Mehta
New England Journal of Medicine. 20142,812 CitationsOPEN ACCESS
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
David W. Andrews, Charles Scott, Paul W. Sperduto, Adam E. Flanders, Laurie E. Gaspar, Michael C. Schell, Maria Werner‐Wasik, William F. Demas, Janice Ryu, Jean-Paul Bahary, Luís Souhami, Marvin Rotman, Minesh P. Mehta, Walter J. Curran
The Lancet. 20042,429 Citations
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki, Gregory A. Masters, George Blumenschein, Steven E. Schild, Jeffrey A. Bogart, Chen Hu, Kenneth Forster, Anthony M. Magliocco, Vivek S. Kavadi, Yolanda I. Garces, Samir Narayan, Puneeth Iyengar, Clifford G. Robinson, Raymond B. Wynn, Christopher D. Koprowski, Joanne Meng, Jonathan J. Beitler, Rakesh Gaur, Walter J. Curran, Hak Choy
The Lancet Oncology. 20152,022 CitationsOPEN ACCESS
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
Anne Aupérin, C. Le Péchoux, Estelle Rolland, Walter J. Curran, Kiyoyuki Furuse, P. Fournel, J. Belderbos, Gerald H. Clamon, H Cüneyt Ulutin, Rebecca Paulus, Takeharu Yamanaka, Marie‐Cécile Bozonnat, A. L. J. Uitterhoeve, Xiaofei Wang, Lesley Stewart, R. Arriagada, Sarah Burdett, Jean‐Pierre Pignon
Journal of Clinical Oncology. 20101,893 CitationsOPEN ACCESS
Related on ScholarIQ
Piedmont Atlanta Hospital
Institution
Lung cancer: current therapies and new targeted treatments
Paper
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Paper
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
Paper
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Paper
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
Paper